U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C65H101N17O16S.C15H12O6
Molecular Weight 1696.919
Optical Activity UNSPECIFIED
Defined Stereocenters 14 / 14
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BACITRACIN B3 METHYLENEDISALICYLATE

SMILES

OC(=O)C1=CC(CC2=CC(C(O)=O)=C(O)C=C2)=CC=C1O.[H][C@](NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]3CSC(=N3)[C@@H](N)[C@@H](C)CC)(C(C)C)C(=O)N[C@H]4CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC5=CNC=N5)NC(=O)[C@@H](CC6=CC=CC=C6)NC(=O)[C@@]([H])(NC(=O)[C@@]([H])(CCCN)NC4=O)[C@@H](C)CC

InChI

InChIKey=FFLIYMRNIOTHMF-VSYREJSLSA-N
InChI=1S/C65H101N17O16S.C15H12O6/c1-9-35(7)51(68)65-80-47(31-99-65)62(96)75-42(25-33(3)4)58(92)73-41(21-22-49(84)85)57(91)81-52(34(5)6)63(97)74-39-19-14-15-24-70-54(88)45(28-48(67)83)77-61(95)46(29-50(86)87)78-60(94)44(27-38-30-69-32-71-38)76-59(93)43(26-37-17-12-11-13-18-37)79-64(98)53(36(8)10-2)82-56(90)40(20-16-23-66)72-55(39)89;16-12-3-1-8(6-10(12)14(18)19)5-9-2-4-13(17)11(7-9)15(20)21/h11-13,17-18,30,32-36,39-47,51-53H,9-10,14-16,19-29,31,66,68H2,1-8H3,(H2,67,83)(H,69,71)(H,70,88)(H,72,89)(H,73,92)(H,74,97)(H,75,96)(H,76,93)(H,77,95)(H,78,94)(H,79,98)(H,81,91)(H,82,90)(H,84,85)(H,86,87);1-4,6-7,16-17H,5H2,(H,18,19)(H,20,21)/t35-,36-,39-,40+,41+,42-,43+,44-,45-,46+,47-,51-,52-,53-;/m0./s1

HIDE SMILES / InChI

Approval Year

Name Type Language
BACITRACIN B3 METHYLENEDISALICYLATE
Common Name English
BACITRACIN B3 METHYLENE DISALICYLATE
Common Name English
Code System Code Type Description
PUBCHEM
73416451
Created by admin on Fri Dec 15 16:12:17 GMT 2023 , Edited by admin on Fri Dec 15 16:12:17 GMT 2023
PRIMARY
FDA UNII
J24NGZ892A
Created by admin on Fri Dec 15 16:12:17 GMT 2023 , Edited by admin on Fri Dec 15 16:12:17 GMT 2023
PRIMARY